BSE filing, NSE: PFIZER. Summary written from the filing by ALFA Finder's alert engine.
Pfizer Ltd: key numbers
- Share price
- ₹3,734.40
- Market cap
- ₹17,084 Cr
- Revenue (annual)
- ₹2,520 Cr
- Net profit (annual)
- ₹722.4 Cr
- P/E (TTM)
- 23.2×Sector 46.1×
- Promoter holding
- 63.92%+0.00% QoQ
- FII holding
- 1.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pfizer Ltd
All →Pfizer Board Meeting Date
Pfizer Limited has scheduled a board meeting for 3 November 2026 to consider unaudited standalone half-yearly results for the period ended September 2026. The trading window closes from 30 September 2026 until 5 November 2026.
Pfizer Legal & Regulatory
Pfizer Limited received a penalty order of Rs. 1.26 Crore from the Income Tax department regarding transfer pricing. The company plans to appeal the order and expects no material financial impact.
- Value
- ₹1.26 Cr
- From
- Deputy / Additional Commissioner of Income tax Transfer Pricing
Pfizer Management Change
Pfizer Limited announced the resignation of Mr. Sharad Goswami, Senior Director – Policy & Public Affairs, effective from the close of business on September 25, 2026.
Pfizer Board Meeting Outcome
Pfizer Board approved discontinuation of Minipress XL effective September 7, 2026. The company will receive ₹131.38 Crore lump-sum payment from Pfizer Inc., USA.
- Value
- ₹131.4 Cr
Pfizer Annual General Meeting
Pfizer Limited held its 75th Annual General Meeting on July 28, 2026. The meeting covered the adoption of financial statements, dividend declaration, and auditor remuneration ratification.
Pfizer Q1 FY27 Results: Net Profit ₹204.5 Cr, Up 6.6% YoY
Pfizer Ltd reported revenue from operations of ₹653.2 Cr (+8.3% YoY) and net profit of ₹204.5 Cr (+6.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹204.5 Cr · +6.6% YoY
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.